California State Teachers Retirement System (CalSTRS)’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.46M | Buy |
258,345
+66,498
| +35% | +$516K | ﹤0.01% | 1406 |
|
|
2025
Q4 | $1.5M | Buy |
191,847
+9,381
| +5% | +$67.8K | ﹤0.01% | 1582 |
|
|
2025
Q3 | $1.38M | Buy |
182,466
+10
| +0% | +$83 | ﹤0.01% | 1616 |
|
|
2025
Q2 | $1.63M | Buy |
182,456
+3,313
| +2% | +$30.9K | ﹤0.01% | 1472 |
|
|
2025
Q1 | $1.34M | Sell |
179,143
-5,342
| -3% | -$43.1K | ﹤0.01% | 1535 |
|
|
2024
Q4 | $1.39M | Buy |
184,485
+7,232
| +4% | +$54.9K | ﹤0.01% | 1601 |
|
|
2024
Q3 | $1.35M | Sell |
177,253
-5,615
| -3% | -$42.7K | ﹤0.01% | 1616 |
|
|
2024
Q2 | $1.13M | Sell |
182,868
-1,920
| -1% | -$10.6K | ﹤0.01% | 1689 |
|
|
2024
Q1 | $939K | Sell |
184,788
-15,173
| -8% | -$85.3K | ﹤0.01% | 1827 |
|
|
2023
Q4 | $1.2M | Sell |
199,961
-8,815
| -4% | -$51.1K | ﹤0.01% | 1723 |
|
|
2023
Q3 | $1.48M | Sell |
208,776
-20,102
| -9% | -$144K | ﹤0.01% | 1571 |
|
|
2023
Q2 | $1.61M | Sell |
228,878
-3,905
| -2% | -$31.3K | ﹤0.01% | 1619 |
|
|
2023
Q1 | $1.94M | Sell |
232,783
-3,067
| -1% | -$29.5K | ﹤0.01% | 1499 |
|
|
2022
Q4 | $2.71M | Buy |
235,850
+2,881
| +1% | +$35.9K | ﹤0.01% | 1301 |
|
|
2022
Q3 | $2.94M | Sell |
232,969
-3,916
| -2% | -$50.4K | 0.01% | 1210 |
|
|
2022
Q2 | $2.51M | Buy |
236,885
+6,077
| +3% | +$62.7K | ﹤0.01% | 1347 |
|
|
2022
Q1 | $3.75M | Sell |
230,808
-18,283
| -7% | -$293K | ﹤0.01% | 1216 |
|
|
2021
Q4 | $3.45M | Buy |
249,091
+6,973
| +3% | +$92.3K | ﹤0.01% | 1393 |
|
|
2021
Q3 | $3.48M | Sell |
242,118
-2,936
| -1% | -$46.3K | ﹤0.01% | 1372 |
|
|
2021
Q2 | $3.87M | Sell |
245,054
-21,305
| -8% | -$289K | ﹤0.01% | 1347 |
|
|
2021
Q1 | $2.71M | Sell |
266,359
-985
| -0.4% | -$10.2K | ﹤0.01% | 1557 |
|
|
2020
Q4 | $1.99M | Hold |
267,344
| – | – | ﹤0.01% | 1652 |
|
|
2020
Q3 | $918K | Buy |
267,344
+33,309
| +14% | +$143K | ﹤0.01% | 1913 |
|
|
2020
Q2 | $1.11M | Buy |
234,035
+5,181
| +2% | +$20.7K | ﹤0.01% | 1803 |
|
|
2020
Q1 | $458K | Buy |
228,854
+2,637
| +1% | +$7.26K | ﹤0.01% | 2109 |
|
|
2019
Q4 | $780K | Buy |
226,217
+54,626
| +32% | +$137K | ﹤0.01% | 2113 |
|
|
2019
Q3 | $492K | Buy |
171,591
+3,302
| +2% | +$10.3K | ﹤0.01% | 2312 |
|
|
2019
Q2 | $638K | Hold |
168,289
| – | – | ﹤0.01% | 2222 |
|
|
2019
Q1 | $1.37M | Sell |
168,289
-10,151
| -6% | -$86.9K | ﹤0.01% | 1757 |
|
|
2018
Q4 | $1.44M | Buy |
178,440
+11,508
| +7% | +$89.5K | ﹤0.01% | 1683 |
|
|
2018
Q3 | $1.27M | Buy |
166,932
+16,224
| +11% | +$109K | ﹤0.01% | 1905 |
|
|
2018
Q2 | $864K | Buy |
150,708
+1,485
| +1% | +$8.18K | ﹤0.01% | 2147 |
|
|
2018
Q1 | $712K | Sell |
149,223
-5,232
| -3% | -$26.9K | ﹤0.01% | 2162 |
|
|
2017
Q4 | $758K | Buy |
154,455
+26,410
| +21% | +$128K | ﹤0.01% | 2158 |
|
|
2017
Q3 | $671K | Sell |
128,045
-13,838
| -10% | -$70.9K | ﹤0.01% | 2242 |
|
|
2017
Q2 | $789K | Sell |
141,883
-15,500
| -10% | -$94.4K | ﹤0.01% | 2203 |
|
|
2017
Q1 | $1.32M | Buy |
157,383
+6,200
| +4% | +$43.1K | ﹤0.01% | 1894 |
|
|
2016
Q4 | $957K | Sell |
151,183
-4,300
| -3% | -$22.4K | ﹤0.01% | 2135 |
|
|
2016
Q3 | $686K | Buy |
155,483
+1,400
| +0.9% | +$5.59K | ﹤0.01% | 2313 |
|
|
2016
Q2 | $438K | Buy |
154,083
+500
| +0.3% | +$1.55K | ﹤0.01% | 2544 |
|
|
2016
Q1 | $435K | Buy |
153,583
+19,157
| +14% | +$84.9K | ﹤0.01% | 2506 |
|
|
2015
Q4 | $1.39M | Buy |
134,426
+2,376
| +2% | +$23.6K | ﹤0.01% | 1802 |
|
|
2015
Q3 | $1.5M | Sell |
132,050
-400
| -0.3% | -$5.34K | ﹤0.01% | 1725 |
|
|
2015
Q2 | $1.98M | Buy |
132,450
+4,563
| +4% | +$51.9K | ﹤0.01% | 1662 |
|
|
2015
Q1 | $1.16M | Sell |
127,887
-1,900
| -1% | -$19.7K | ﹤0.01% | 1936 |
|
|
2014
Q4 | $1.58M | Buy |
129,787
+553
| +0.4% | +$6.11K | ﹤0.01% | 1746 |
|
|
2014
Q3 | $1.26M | Buy |
129,234
+1,334
| +1% | +$16.3K | ﹤0.01% | 1842 |
|
|
2014
Q2 | $1.63M | Buy |
+127,900
| New | +$1.24M | ﹤0.01% | 1744 |
|
Other funds holding BCRX
RCM
DM
VPM
VCM
TCM
PA
VPC